These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7814188)

  • 41. Serum-sickness-like illness as a complication after streptokinase therapy for acute myocardial infarction.
    Schweitzer DH; van der Wall EE; Bosker HA; Scheffer E; Macfarlane JD
    Cardiology; 1991; 78(1):68-71. PubMed ID: 2021968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics.
    Lancet; 1995 Aug; 346(8971):329-36. PubMed ID: 7623530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Changes in liver enzymes during treatment with diltiazem. Description of 2 cases].
    Romanò M; Colombo E; Spinelli A
    G Ital Cardiol; 1987 Feb; 17(2):149-50. PubMed ID: 2886392
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Acute myocardial infarction: thrombolytic efficacy of 500.000 UI of streptokinase combined with heparin].
    Aninat M; Col JJ; Rankin J; Jacquet L; Anwar A; Etienne J
    Rev Med Chil; 1990 Aug; 118(8):862-7. PubMed ID: 2152229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase.
    Salvioni A; Marenzi GC; Agostoni P; Grazi S; Guazzi MD
    Eur Heart J; 1994 May; 15(5):654-9. PubMed ID: 8056006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The need to identify patients who have received streptokinase therapy.
    Salem DN; Pauker SG
    N Engl J Med; 1991 Jun; 324(24):1742. PubMed ID: 2034254
    [No Abstract]   [Full Text] [Related]  

  • 47. Coronary arterial aneurysm after percutaneous transluminal coronary recanalization with streptokinase.
    Chen MF; Liau CS; Lee YT
    Int J Cardiol; 1990 Jul; 28(1):117-9. PubMed ID: 2365525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Streptokinase-induced jaundice].
    Gómez Guindal JA; Roldán Rabadán I; Perea Egido J; Jurado López JA; García de Frutos A; Martín Jadraque L
    Rev Esp Cardiol; 1999 Nov; 52(11):1025-7. PubMed ID: 10611814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparin-induced hepatotoxicity.
    AL-Mekhaizeem KA; Sherker AH
    Can J Gastroenterol; 2001 Aug; 15(8):527-30. PubMed ID: 11544537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Increased transaminases--differential diagnosis and evaluation].
    Elke B; Battegay E; Müllhaupt B
    Praxis (Bern 1994); 2008 May; 97(11):587-96; quiz 596-7. PubMed ID: 18592953
    [No Abstract]   [Full Text] [Related]  

  • 51. Thrombolytic therapy for acute myocardial infarction following recent cataract surgery.
    Glikson M; Feinberg M; Hod H; Kaplinsky E
    Am Heart J; 1991 May; 121(5):1542-3. PubMed ID: 2017986
    [No Abstract]   [Full Text] [Related]  

  • 52. Rescue angioplasty after thrombolysis.
    Owen A
    N Engl J Med; 2006 Apr; 354(15):1639-41; author reply 1639-41. PubMed ID: 16611958
    [No Abstract]   [Full Text] [Related]  

  • 53. Hypersensitive reactions on readministration of streptokinase following acute myocardial infarction.
    Sahay RN; Kalantri SP; Gupta OP
    J Assoc Physicians India; 1994 Oct; 42(10):815. PubMed ID: 7876052
    [No Abstract]   [Full Text] [Related]  

  • 54. Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase.
    Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
    J Am Coll Cardiol; 1994 Nov; 24(6):1445-52. PubMed ID: 7930274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticoagulation.
    Chong BH
    Aust Fam Physician; 1996 Jan; 25(1):74-8. PubMed ID: 8607780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late adverse effects of streptokinase.
    Chesterman CN
    Aust N Z J Med; 1992 Apr; 22(2):106-8. PubMed ID: 1388351
    [No Abstract]   [Full Text] [Related]  

  • 57. [Gamma-glutamyltranspeptidase in occupational exposure to hepatotoxic material and certain diseases].
    Oresković-Dulizibarić D; Siriski J; Dulizibarić J
    Med Pregl; 1988; 41(9-10):359-61. PubMed ID: 2907998
    [No Abstract]   [Full Text] [Related]  

  • 58. [CNS hemorrhage after drug induced thrombolysis in suspected myocardial infarction].
    Rabow L; Bergenheim T; Fagerlund M
    Lakartidningen; 1991 Feb; 88(7):492, 494-5. PubMed ID: 1999997
    [No Abstract]   [Full Text] [Related]  

  • 59. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
    Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM
    Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
    N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.